What’s the current market cap for Phreesia stock?

Phreesia (PHR) has a market cap of $574m as of June 10, 2026.

What is the P/E ratio for Phreesia stock?

The price to earnings (P/E) ratio for Phreesia (PHR) stock is 60.95 as of June 10, 2026.

Does Phreesia stock pay dividends?

No, Phreesia (PHR) stock does not pay dividends to its shareholders as of June 10, 2026.

When is the next Phreesia dividend payment date?

Phreesia (PHR) stock does not pay dividends to its shareholders.

What is the beta indicator for Phreesia?

Phreesia (PHR) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Phreesia stock | $PHR Share Price

About Phreesia

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

Ticker

$PHR

Sector

Health

Primary listing

NYSE

Employees

1,789

Headquarters

Wilmington, United States

Website

www.phreesia.com

Phreesia Metrics

BasicAdvanced

$574m

60.95

$0.15

0.88

-

What the Analysts think about Phreesia

Analyst ratings (Buy, Hold, Sell) for Phreesia stock.

Bulls say / Bears say

Strong Q1 FY2027 results: revenue of $130.9 million, up 13% year-over-year, adjusted EBITDA of $30.5 million (+47%), free cash flow more than doubled, and management reaffirmed full-year guidance, underscoring robust momentum (Reuters)

In Q4 FY2026, Phreesia achieved its first positive GAAP net income of $2.3 million, exceeded $100 million in adjusted EBITDA, and generated $50 million+ in free cash flow, highlighting rapid progression toward sustained profitability (Businesswire)

On April 30, 2026, Phreesia expanded its securitization facility with PNC Bank via a $110 million bridge loan, bolstering liquidity and underwriting capacity to support its AccessOne payment solution and future growth (Reuters)

Full-year FY2027 guidance implies only ~1% organic revenue growth at the midpoint, marking a sharp deceleration from historical double-digit growth rates and raising concerns about future momentum (Reuters)

A securities class action was filed in May 2026 in the U.S. District Court for the District of Delaware alleging misstatements in revenue projections, exposing the company to legal costs, reputational risk, and potential financial liabilities (GlobeNewswire)

Despite improved cash flow, Q4 FY2026 GAAP net income margin stood at only ~1% ($1.3 million on $127.1 million revenue), indicating limited net profitability buffer against market downturns or increased competition (Businesswire)

Data summarised monthly by Lightyear AI. Last updated on 3 Jun 2026.

Phreesia Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Phreesia Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Phreesia News

AllArticlesVideos

PHR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026

Newsfile Corp·7 hours ago

PHR Shareholder Alert: Phreesia, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Business Wire·1 day ago

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Newsfile Corp·1 day ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.